{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:22:29Z","timestamp":1779891749885,"version":"3.53.1"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>We presented a case of 67-year-old man with epigastric discomfort and anorexia for more than 2 months. No abnormal <jats:sup>18<\/jats:sup>F-FDG uptake was found throughout the gastrointestinal tract on <jats:sup>18<\/jats:sup>F-FDG PET\/CT. The patient was enrolled in the <jats:sup>68<\/jats:sup>Ga-FAPI PET\/CT clinical trial, and a <jats:sup>68<\/jats:sup>Ga-FAPI PET\/CT was performed to help detect primary lesion. This examination demonstrated a nodular thickening of the gastric wall with an increased <jats:sup>68<\/jats:sup>Ga-FAPI uptake in the greater curvature of the stomach. Finally, the pathological result confirmed the diagnosis of gastric stromal tumor. This case highlights that <jats:sup>68<\/jats:sup>Ga-FAPI PET\/CT might outperform <jats:sup>18<\/jats:sup>F-FDG PET\/CT in helping identify gastrointestinal stromal tumors.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003856","type":"journal-article","created":{"date-parts":[[2021,8,15]],"date-time":"2021-08-15T22:02:26Z","timestamp":1629064946000},"page":"226-227","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["68Ga-FAPI PET\/CT Detected Non\u2013FDG-Avid Gastric Stromal Tumor"],"prefix":"10.1097","volume":"47","author":[{"given":"Lin","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianjun","family":"Lan","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanxiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s00259-003-1198-x","article-title":"Rapid normalization of osseous FDG uptake following traumatic or surgical fractures","volume":"30","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s001980200103","article-title":"FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results","volume":"13","year":"2002","journal-title":"Osteoporos Int"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/prca.201300095","article-title":"Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy","volume":"8","year":"2014","journal-title":"Proteomics Clin Appl"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"(68)Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers","volume":"60","year":"2019","journal-title":"J Nucl Med"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00259-020-05070-9","article-title":"Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/RLU.0000000000003000","article-title":"68Ga-FAPI PET\/CT improves therapeutic strategy by detecting a second primary malignancy in a patient with rectal cancer","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/RLU.0000000000003099","article-title":"68Ga-FAPI PET\/CT detects gastric signet-ring cell carcinoma in a patient previously treated for prostate cancer","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/RLU.0000000000003245","article-title":"Widespread metastatic gastric signet-ring cell carcinoma shown by 68Ga-FAPI PET\/CT","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1148\/radiol.2020202469","article-title":"(68)Ga FAPI PET\/CT imaging in peritoneal carcinomatosis","volume":"297","year":"2020","journal-title":"Radiology"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/RLU.0000000000003231","article-title":"68Ga-FAPI PET\/CT in assessment of leptomeningeal metastases in a patient with lung adenocarcinoma","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00259-020-04997-3","article-title":"The superiority of [(68)Ga]-FAPI-04 over [(18)F]-FDG PET\/CT in imaging metastatic esophageal squamous cell carcinoma","volume":"48","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:05:52Z","timestamp":1750536352000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003856","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,13]]}}}